{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T16:52:03Z","timestamp":1760028723468},"reference-count":28,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2009,9]]},"DOI":"10.1097\/mbc.0b013e32832c87b3","type":"journal-article","created":{"date-parts":[[2009,8,13]],"date-time":"2009-08-13T18:49:57Z","timestamp":1250189397000},"page":"427-432","source":"Crossref","is-referenced-by-count":3,"title":["The clinical importance of laboratory-defined aspirin resistance in patients presenting with non-ST elevation acute coronary syndromes"],"prefix":"10.1097","volume":"20","author":[{"given":"Sadik","family":"Acikel","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aylin","family":"Yildirir","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alp","family":"Aydinalp","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ugur","family":"Bal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gamze","family":"Kaynar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bulent","family":"Ozin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haldun","family":"Muderrisoglu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-7-20210203","first-page":"1243","article-title":"Unstable angina and non-ST elevation myocardial infarction","author":"Cannon","year":"2005"},{"key":"R2-7-20210203","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1161\/01.CIR.100.15.1593","article-title":"Enoxaparin prevents death and cardiac ischemic events in unstable angina\/non-Q-wave myocardial infarction. Results of the thrombolysis in myocardial infarction (TIMI) 11B trial","volume":"100","author":"Antman","year":"1999","journal-title":"Circulation"},{"key":"R3-7-20210203","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1056\/NEJM199708143370702","article-title":"A comparison of low-molecular-weight heparin with unfractionated heparin for unstable coronary artery disease. Efficacy and Safety of Subcutaneous Enoxaparin in Non-Q-Wave Coronary Events Study Group","volume":"337","author":"Cohen","year":"1997","journal-title":"N Engl J Med"},{"key":"R4-7-20210203","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.1056\/NEJM199805213382102","article-title":"Inhibition of the platelet glycoprotein IIb\/IIIa receptor with tirofiban in unstable angina and non-Q-wave myocardial infarction.","volume":"338","year":"1998","journal-title":"N Engl J Med"},{"key":"R5-7-20210203","doi-asserted-by":"crossref","first-page":"1879","DOI":"10.1056\/NEJM200106213442501","article-title":"Comparison of early invasive and conservative strategies in patients with unstable coronary syndromes treated with the glycoprotein IIb\/IIIa inhibitor tirofiban","volume":"344","author":"Cannon","year":"2001","journal-title":"N Engl J Med"},{"key":"R6-7-20210203","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1136\/bmj.308.6921.81","article-title":"Collaborative overview of randomised trials of antiplatelet therapy: I: prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients.","volume":"308","year":"1994","journal-title":"BMJ"},{"key":"R7-7-20210203","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1136\/bmj.324.7329.71","article-title":"Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high-risk patients.","volume":"324","year":"2002","journal-title":"BMJ"},{"key":"R8-7-20210203","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/0049-3848(93)90164-J","article-title":"Two-year follow-up of aspirin responder and aspirin non responder. A pilot-study including 180 poststroke patients","volume":"71","author":"Grotemeyer","year":"1993","journal-title":"Thromb Res"},{"key":"R9-7-20210203","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.1161\/01.CIR.0000013777.21160.07","article-title":"Aspirin-resistant thromboxane biosynthesis and the risk of myocardial infarction, stroke, or cardiovascular death in patients at high risk for cardiovascular events","volume":"105","author":"Eikelboom","year":"2002","journal-title":"Circulation"},{"key":"R10-7-20210203","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1016\/S0735-1097(02)03014-0","article-title":"A prospective, blinded determination of the natural history of aspirin resistance among stable patients with cardiovascular disease","volume":"41","author":"Gum","year":"2003","journal-title":"J Am Coll Cardiol"},{"key":"R11-7-20210203","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1016\/j.jacc.2003.12.034","article-title":"Aspirin resistance is associated with a high incidence of myonecrosis after nonurgent percutaneous coronary intervention despite clopidogrel pretreatment","volume":"43","author":"Chen","year":"2004","journal-title":"J Am Coll Cardiol"},{"key":"R12-7-20210203","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/S0049-3848(02)00405-X","article-title":"Aspirin nonresponsiveness as measured by PFA-100 in patients with coronary artery disease","volume":"108","author":"Andersen","year":"2002","journal-title":"Thromb Res"},{"key":"R13-7-20210203","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/S0049-3848(02)00210-4","article-title":"Resistance to aspirin in vitro is associated with increased platelet sensitivity to adenosine diphosphate","volume":"107","author":"Macchi","year":"2002","journal-title":"Thromb Res"},{"key":"R14-7-20210203","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1055\/s-2007-995840","article-title":"PFA-100 system: a new method for assessment of platelet dysfunction","volume":"24","author":"Mammen","year":"1998","journal-title":"Semin Thromb Hemost"},{"key":"R15-7-20210203","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1016\/S0735-1097(00)00804-4","article-title":"Myocardial infarction redefined: a consensus document of The Joint European Society of Cardiology\/American College of Cardiology Committee for the redefinition of myocardial infarction","volume":"36","author":"Alpert","year":"2000","journal-title":"J Am Coll Cardiol"},{"key":"R16-7-20210203","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1001\/jama.284.7.835","article-title":"The TIMI risk score for unstable angina\/non-ST elevation MI: a method for prognostication and therapeutic decision making","volume":"284","author":"Antman","year":"2000","journal-title":"JAMA"},{"key":"R17-7-20210203","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1016\/S0002-9149(99)00049-1","article-title":"Prior aspirin use predicts worse outcomes in patients with non-ST-elevation acute coronary syndromes. PURSUIT investigators. Platelet IIb\/IIIa in unstable angina: Receptor Suppression Using Integrilin Therapy","volume":"83","author":"Alexander","year":"1999","journal-title":"Am J Cardiol"},{"key":"R18-7-20210203","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1161\/01.CIR.0000141575.92958.9C","article-title":"Platelet function predicts myocardial damage in patients with acute myocardial infarction","volume":"110","author":"Frossard","year":"2004","journal-title":"Circulation"},{"key":"R19-7-20210203","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/j.thromres.2006.04.005","article-title":"Prevalence of aspirin resistance in patients with an evolving acute myocardial infarction","volume":"119","author":"Poulsen","year":"2007","journal-title":"Thromb Res"},{"key":"R20-7-20210203","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1007\/s11239-006-8952-4","article-title":"The role of aspirin resistance on outcome in patients with acute coronary syndrome and the effect of clopidogrel therapy in the prevention of major cardiovascular events","volume":"22","author":"Pamukcu","year":"2006","journal-title":"J Thromb Thrombolysis"},{"key":"R21-7-20210203","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1001\/archinte.167.15.1593","article-title":"Association of laboratory-defined aspirin resistance with a higher risk of recurrent cardiovascular events: a systematic review and meta-analysis","volume":"167","author":"Snoep","year":"2007","journal-title":"Arch Intern Med"},{"key":"R22-7-20210203","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1111\/j.1538-7836.2008.02897.x","article-title":"Use of the PFA-100 closure time to predict cardiovascular events in aspirin-treated cardiovascular patients: a systematic review and meta-analysis","volume":"6","author":"Reny","year":"2008","journal-title":"J Thromb Haemost"},{"key":"R23-7-20210203","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1160\/TH08-03-0198","article-title":"Response variability to aspirin as assessed by the platelet function analyzer (PFA)-100. A systematic review","volume":"99","author":"Crescente","year":"2008","journal-title":"Thromb Haemost"},{"key":"R24-7-20210203","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1160\/TH08-03-0130","article-title":"PFA-100 closure time to predict cardiovascular events in aspirin-treated cardiovascular patients: a meta-analysis of 19 studies comprising 3003 patients","volume":"99","author":"Crescente","year":"2008","journal-title":"Thromb Haemost"},{"key":"R25-7-20210203","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.1016\/j.jacc.2007.11.080","article-title":"The role of aspirin in cardiovascular prevention: implications of aspirin resistance","volume":"51","author":"Gasparyan","year":"2008","journal-title":"J Am Coll Cardiol"},{"key":"R26-7-20210203","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1046\/j.1365-2141.2003.04727.x","article-title":"In vitro aspirin resistance detected by PFA-100 closure time: pivotal role of plasma von Willebrand factor","volume":"124","author":"Chakroun","year":"2004","journal-title":"Br J Haematol"},{"key":"R27-7-20210203","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1097\/MBC.0b013e32830ef92b","article-title":"Aspirin \u2018responsiveness\u2019, \u2018nonresponsiveness\u2019 or \u2018resistance\u2019: a putative role for von Willebrand factor?","volume":"19","author":"Kilanowska","year":"2008","journal-title":"Blood Coagul Fibrinolysis"},{"key":"R28-7-20210203","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1055\/s-0029-1145254","article-title":"Clinical utility of the PFA-100","volume":"34","author":"Favaloro","year":"2008","journal-title":"Semin Thromb Hemost"}],"container-title":["Blood Coagulation & Fibrinolysis"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/journals.lww.com\/00001721-200909000-00007","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,10]],"date-time":"2021-04-10T06:10:33Z","timestamp":1618035033000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00001721-200909000-00007"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,9]]},"references-count":28,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2009]]}},"URL":"https:\/\/doi.org\/10.1097\/mbc.0b013e32832c87b3","relation":{},"ISSN":["0957-5235"],"issn-type":[{"value":"0957-5235","type":"print"}],"subject":[],"published":{"date-parts":[[2009,9]]}}}